United StatesJohn Parker
Australian engineer and neurotechnology researcher (PhD) who founded Saluda Medical in 2013 after spinning it out of NICTA, Australia's national information-and-communications-technology research centre of excellence, where he started and led the Implant Systems team that developed the closed-loop ECAP feedback technology. His core insight—that directly measuring the spinal cord's objective electrical response (the Evoked Compound Action Potential) could close the loop on neuromodulation therapy—became the foundation of the Evoke system. Before Saluda he spent 13 years at Cochlear Limited, the cochlear-implant pioneer, where he served as Chief Technology Officer and an executive member of the board, accumulating more than 20 years in implantable medical devices. He served as Saluda's founding CEO and, following the 2021 leadership transition, moved to Chief Scientific Officer while remaining on the company's board of directors.